Clinical significance of IgA anticardiolipin and anti-β2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome
- 1 March 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical Rheumatology
- Vol. 25 (2), 199-204
- https://doi.org/10.1007/s10067-005-1156-z
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- IgG subclass distribution of antibodies against β2‐GP1 and cardiolipin in patients with systemic lupus erythematosus and primary antiphospholipid syndrome, and their clinical associationsRheumatology, 2001
- HLA class II alleles associations of anticardiolipin and anti b2GPI antibodies in a large series of European patients with systemic lupus erythematosusLupus, 2000
- Class specific rheumatoid factors and antiphospholipid syndrome in systemic lupus erythematosusLupus, 2000
- IgA Anticardiolipin and Anti-??2-Glycoprotein I Are the Most Prevalent Isotypes in African American Patients with Systemic Lupus ErythematosusThe American Journal of the Medical Sciences, 1999
- Anticardiolipin and anti-β2glycoprotein-I antibodies in patients with systemic lupus erythematosus: Comparison between Colombians and SpaniardsLupus, 1999
- Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disordersClinical and Experimental Immunology, 1992
- Measurement of anti-phospholipid antibodies by ELISA using β2-glycoprotein I as an antigenJournal of Immunological Methods, 1991
- Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive PatientsMedicine, 1989
- Anticardiolipin antibodies: isotype distribution and phospholipid specificity.Annals Of The Rheumatic Diseases, 1987
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982